The Cell Immunotherapy Platform market refers to the development and application of cell-based immunotherapies for the treatment of various diseases. As the Cell Immunotherapy Platform market size is expected to grow significantly, understanding the growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses the development of cell-based therapies, including CAR-T cell therapy, TCR-T cell therapy, and tumor-infiltrating lymphocyte (TIL) therapy, among others. With a current market size of approximately $7.8 billion, the Cell Immunotherapy Platform market is poised for substantial growth, driven by a Compound Annual Growth Rate (CAGR) of around 22.5% from 2026 to 2033. Key forces shaping the industry include technology shifts, such as advancements in gene editing and cell engineering, regulatory developments, including the implementation of new guidelines for cell therapy manufacturing, and competitive intensity, driven by the increasing number of market players.